Biomarkers

Alzheimers Dement. 2024 Dec:20 Suppl 2:e091203. doi: 10.1002/alz.091203.

Abstract

Background: While some memory decline in old age is "normal", there are some older individuals with maintained high cognitive performance. Using a multimodal approach including neuroimaging, fitness, genetic and questionnaire data (Figure 1A), we aimed to identify factors that are related to successful cognitive aging and whether these differ between sexes.

Method: We analyzed 165 cognitively normal older adults age ≥ 60 years from an ongoing study (SFB1436) (age=71±8years, 43% female). For all participants, we determined plasma Abeta1-42/Abeta1-40. Temporal lobe tau burden was estimated by [18F]PI-2620 in a subsample (see Figure 1A for sample sizes). We assessed global white matter hyperintensity (WMH) volumes and gray matter thickness for medial temporal lobe (MTL), anterior cingulate cortex (ACC) and whole brain. We measured aerobic and muscular capacity (and blood pressure) by fitness assessment and trait/state anxiety by self-reports. Genetic profiling included KLOTHO and KIBRA polymorphisms and APOE genotype. To phenotype successful cognitive aging, we i) grouped individuals age ≥ 79.5 years into SuperAgers (N=18) based on delayed verbal recall performance ≥ normative values at age of 50-60 years versus typical agers (N=19). For the whole sample we ii) calculated cognitive age gap (CAG) as the difference between cognition-predicted age and chronological age (Figure 3A). We assessed how markers of pathology, brain structure, fitness, mental health and genetics were related to CAG, covarying for chronological age, sex and education.

Result: SuperAgers and typical agers did not differ in age, sex, education, fitness, anxiety or Abeta42/40 (all p-values>0.1). However, SuperAgers had less WMH volume, higher ACC thickness, lower blood pressure and less temporal lobe tau-tracer binding (small subgroup; ). In the whole sample, younger cognitive age related to higher MTL and global cortical thickness, less temporal tau-tracer binding, less anxiety (all p<0.05; Figure 3B) and marginally to higher muscular capacity (p=.06). Only the association between anxiety measures and CAG was moderated by sex (Figure 3B). CAG was not related to genotype.

Conclusion: Our results suggest that successful cognitive aging is related to resistance against age-related pathology and higher brain integrity. Younger cognitive age is linked to better mental health, especially in females.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging / genetics
  • Aging / physiology
  • Amyloid beta-Peptides* / metabolism
  • Apolipoproteins E / genetics
  • Biomarkers* / blood
  • Brain / diagnostic imaging
  • Brain / pathology
  • Cognitive Aging / physiology
  • Female
  • Genotype
  • Gray Matter / diagnostic imaging
  • Gray Matter / pathology
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neuropsychological Tests / statistics & numerical data
  • Peptide Fragments / blood
  • White Matter / diagnostic imaging
  • White Matter / pathology
  • tau Proteins

Substances

  • Biomarkers
  • Amyloid beta-Peptides
  • tau Proteins
  • Apolipoproteins E
  • Peptide Fragments